Spinal subpial delivery of AAV9 enables widespread gene silencing and blocks motoneuron degeneration in ALS
- 1 January 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 26 (1), 118-+
- https://doi.org/10.1038/s41591-019-0674-1
Abstract
Injection of AAV-shRNA below the pial surface of the spinal cord prevents onset or ameliorates progression in a mouse model of ALS, and achieves widespread delivery to the spinal cord and brain motor centers in adult pigs and non-human primates. Gene silencing with virally delivered shRNA represents a promising approach for treatment of inherited neurodegenerative disorders. In the present study we develop a subpial technique, which we show in adult animals successfully delivers adeno-associated virus (AAV) throughout the cervical, thoracic and lumbar spinal cord, as well as brain motor centers. One-time injection at cervical and lumbar levels just before disease onset in mice expressing a familial amyotrophic lateral sclerosis (ALS)-causing mutant SOD1 produces long-term suppression of motoneuron disease, including near-complete preservation of spinal alpha-motoneurons and muscle innervation. Treatment after disease onset potently blocks progression of disease and further alpha-motoneuron degeneration. A single subpial AAV9 injection in adult pigs or non-human primates using a newly designed device produces homogeneous delivery throughout the cervical spinal cord white and gray matter and brain motor centers. Thus, spinal subpial delivery in adult animals is highly effective for AAV-mediated gene delivery throughout the spinal cord and supraspinal motor centers.This publication has 42 references indexed in Scilit:
- Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosisNature Neuroscience, 2013
- Human Neural Stem Cell Replacement Therapy for Amyotrophic Lateral Sclerosis by Spinal TransplantationPLOS ONE, 2012
- In Vivo Gene Knockdown in Rat Dorsal Root Ganglia Mediated by Self-Complementary Adeno-Associated Virus Serotype 5 Following Intrathecal DeliveryPLOS ONE, 2012
- Improved Function of the Failing Rat Heart by Regulated Expression of Insulin-Like Growth Factor I via Intramuscular Gene TransferHuman Gene Therapy, 2012
- Sensorimotor and cognitive functions in a SOD1G37R transgenic mouse model of amyotrophic lateral sclerosisBehavioural Brain Research, 2011
- Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyondThe Journal of cell biology, 2009
- Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS miceProceedings of the National Academy of Sciences of the United States of America, 2008
- Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosisNature Neuroscience, 2008
- Antisense oligonucleotide therapy for neurodegenerative diseaseJCI Insight, 2006
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993